Effects of veliflapon on biomarkers of the risk of myocardial infarction.

Trial Profile

Effects of veliflapon on biomarkers of the risk of myocardial infarction.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Nov 2010

At a glance

  • Drugs Veliflapon (Primary)
  • Indications Myocardial infarction
  • Focus Pharmacodynamics
  • Sponsors deCODE genetics
  • Most Recent Events

    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top